Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients

<div>Identification of the anoikis-related signature (ARS). (a) LASSO regression analysis for the development of ARS. (b) LASSO coefficient of anoikis-related genes in EC.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients 